SEC 13F Intelligence

Carlson Capital, L.P. / ITCIEUR

Carlson Capital, L.P.’s Intra-Cellular Therapies Inc Position

Does Carlson Capital, L.P. own Intra-Cellular Therapies Inc (ITCIEUR)? Not currently — the last reported position was 23.0K shares worth $3M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q1 2025
Shares
23.0K
% of Portfolio
+1.18%
Quarters Held
1
position exited

Position History ITCIEUR

Reported value by quarter
Q1 ’25: $3MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202523.0K$3M+1.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of ITCIEUR.